CRISPR/Cas9 genome editing to treat sickle cell disease
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
Yazar: | Ullah, Mohammad |
---|---|
Diğer Yazarlar: | Islam, Farzana |
Materyal Türü: | Tez |
Dil: | English |
Baskı/Yayın Bilgisi: |
Brac University
2023
|
Konular: | |
Online Erişim: | http://hdl.handle.net/10361/19355 |
Benzer Materyaller
-
CRISPR/Cas9 system: A versatile gene editing tool in disease prevention and treatment
Yazar:: Maria, Amatul
Baskı/Yayın Bilgisi: (2020) -
Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
Yazar:: Shaikat, Mahdi Mubin
Baskı/Yayın Bilgisi: (2023) -
A review on CRISPR-Cas system based applications in Oncology
Yazar:: Sadia, Mir
Baskı/Yayın Bilgisi: (2022) -
A review on CRISPR Technology as an Antiviral Tool
Yazar:: Srishti, Sanjida Ahmed
Baskı/Yayın Bilgisi: (2023) -
CRISPR: a revolutionary tool for modeling and treating cancer and Duchenne muscular dystrophy
Yazar:: Eva, Israt Ara Jannat
Baskı/Yayın Bilgisi: (2023)